Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by Qwerty123456on Jan 04, 2020 7:55pm
92 Views
Post# 30518950

RE:Is the bottom in now that shares are trading in the US?

RE:Is the bottom in now that shares are trading in the US?
ChupacabraBueno wrote: US trading range Jan 03 was = 11.69 to !2.03 $Cdn. That's still under $9 million market cap, but well up from the $10.50 we were trading at ealier this week & early Dec.

Were those lows the temporary effect of tax loss selling in early December and shareholders disenchanted by the reverse split this week? Does US money coming in mean that there's little chance of seeing those lows agian? Does US money coming in mean that the current price is a bargain that won't last? Or will the prospect of a future PP hold the price down?  


All very good questions Chupacabra. IMO the bottom is in but alas I also thought the share price would be higher than it is now. Hopefully management has a plan forward plus some positive annoucement short term that generates interest and support for the stock. Guess we'll see.
Bullboard Posts